Transition to Adulthood through Coaching and Empowerment in Rheumatology (TRACER): A feasibility study protocol.
Emma ReesorDorota BorovskyJulie HerringtonPamela JarvisMegan ClarkeRoberta BerardKaren BeattieMichelle BatthishPublished in: PloS one (2024)
The transition from pediatric to adult care for patients with chronic disease is a vulnerable period, with risks of disengagement from care and subsequent complications of inadequately managed disease. This period comes at a time when there are many other transitions occurring in the young person's life, including changes to vocation, social supports, and to their physiology. The aim of the TRACER study is to assess the feasibility of conducting a multi-center, randomized-controlled trial of a virtual Transition Coach Intervention in youth transferring from pediatric to adult rheumatology care. Patients are being recruited at their last pediatric rheumatology visit from McMaster Children's Hospital and Children's Hospital, London Health Sciences Centre in Ontario, Canada. Participants are then randomized to standard of care or to eight transition coaching sessions, covering topics around health management, future planning, and self-advocacy. The primary outcomes of the study are to demonstrate protocol feasibility, including optimal recruitment and consent rates, ≥ 90% coaching session completion, and complete data collection with ≤ 5% missing data. Baseline demographics, transition readiness, global functional assessment, disease activity, and self-efficacy will be collected to characterize the study population. Recruitment has begun and is estimated to last 19 months. This study will inform the design of a robust, multi-centered, randomized-controlled study to investigate the impact of a virtual transition coaching program in supporting the physical, mental, and social well-being of youth with rheumatic disease transitioning into adult care. Clinical trial registration: ClinicalTrials.Gov protocol ID: 14499.
Keyphrases
- healthcare
- randomized controlled trial
- mental health
- palliative care
- clinical trial
- quality improvement
- disease activity
- young adults
- physical activity
- rheumatoid arthritis
- public health
- open label
- type diabetes
- emergency department
- juvenile idiopathic arthritis
- study protocol
- phase iii
- double blind
- machine learning
- computed tomography
- ejection fraction
- newly diagnosed
- adipose tissue
- metabolic syndrome
- climate change
- affordable care act
- rheumatoid arthritis patients
- chronic kidney disease
- weight loss
- insulin resistance
- current status
- prognostic factors
- risk factors
- placebo controlled
- adverse drug
- working memory